Article
Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
8 Jan 2019
Abstract excerpt
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and the prognosis of MM patients remains poor. Objective: To identify and validate a genetic prognostic signature in patients with MM. Methods: Co-expression network was constructed to identify hub genes related with International Staging System (ISS) stage of MM. Functional analysis of hub genes was conducted....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
